Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm

Human Pathology

Volumn 39, Issue 8, 2008, Pages 1153-1161

  Nakanishi, Yoshitsugu ^a,b,c   Zen, Yoh ^a   Kondo, Satoshi ^b   Itoh, Tomoo ^c   Itatsu, Keita ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Biliary dysplasia; BilIN; Cell cycle; DPC4; Intraductal papillary neoplasm

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; PROTEIN P21; PROTEIN P53; SMAD4 PROTEIN;

ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT TUMOR; CARCINOGENESIS; CELL CYCLE; DOWN REGULATION; EPITHELIUM; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MOLECULE; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CA-15-3 ANTIGEN; CELL CYCLE PROTEINS; CHOLANGIOCARCINOMA; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCINS; PRECANCEROUS CONDITIONS; SMAD4 PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 47549104922     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.11.018     Document Type: Article

References (34)

1. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
2. Pardee A.B. G1 events and regulation of cell proliferation. Science 246 (1989) 603-608
3. Matsushima H., Ewen M.E., Storm D.K., et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk) for mammalian D type G1 cyclins. Cell 71 (1992) 323-334
4. Serrano M., Hannon G.J., and Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
5. Waga S., Hannon G.J., Beach D., and Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 (1994) 520-521
6. el-Deiry W.S., Harper J.W., O'Connor P.M., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54 (1994) 1169-1174
7. Hahn S.A., Schutte M., Hoque A.T., et al. dDPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 (1996) 350-353
8. Lagna G., Hata A., Hemmati-Brivanlou A., and Massague J. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383 (1996) 832-836
9. Shimonishi T., Sasaki M., and Nakanuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7 (2000) 542-550
10. Nakanuma Y., Sasaki M., Ishikawa A., Tsui W., Chen T.C., and Huang S.F. Biliary papillary neoplasm of the liver. Histol Histopathol 17 (2002) 851-861
11. Nakanuma Y., Harada K., Ishikawa A., Zen Y., and Sasaki M. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 10 (2003) 265-281
12. Nakanuma Y., Sripa B., Vatanasapt V., Leong A.S.-Y., Ponchon T., and Ishak K.G. Intrahepatic cholangiocarcinoma. In: Hamilton S.R., and Aaltonen L.A. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system (2000), IARC Press, Lyon, France 173-180
13. Chen T.C., Nakanuma Y., Zen Y., et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34 (2001) 651-658
14. Zen Y., Sasaki M., Fujii T., et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 44 (2006) 350-358
15. Shimonishi T., Zen Y., Chen T.C., et al. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol 33 (2002) 503-511
16. Nakanuma Y., Hoso M., Sanzen T., and Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 38 (1997) 552-570
17. Zen Y., Adsay N.V., Bardadin K., et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20 (2007) 701-709
18. Longnecker D.S., Adler G., Hruban R.H., and Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton S.R., and Aaltonen L.A. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System (2000), IARC Press, Lyon 237-240
19. Furukawa T., Kloppel G., Volkan N., et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 447 (2005) 794-799
20. Biankin A.V., Kench J.G., Morey A.L., et al. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res 61 (2001) 8830-8837
21. Biankin A.V., Kench J.G., Biankin S.A., et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence. Am J Surg Pathol 28 (2004) 1184-1192
22. Ishikawa A., Sasaki M., Sato Y., et al. Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis. Hum Pathol 35 (2004) 1505-1514
23. Zen Y., Fujii T., Itatsu K., et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 44 (2006) 1333-1343
24. Shibahara H., Tamada S., Goto M., et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 28 (2004) 327-338
25. Schutte M., Hruban R.H., Hedrick L., et al. DPC4 gene in various tumor types. Cancer Res 56 (1996) 2527-2530
26. Moskaluk C.A., Hruban R.H., Schutte M., et al. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma. Diagn Mol Pathol 6 (1997) 85-90
27. Wilentz R.E., Su G.H., Dai J.L., et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am J Pathol 156 (2000) 37-43
28. Wilentz R.E., Iacobuzio-Donahue C.A., Argani P., et al. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60 (2000) 2002-2006
29. Iacobuzio-Donahue C.A., Klimstra D.S., Adsay N.V., et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 157 (2000) 755-761
30. Luttges J., Zamboni G., Longnecker D., and Kloppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 25 (2001) 942-948
31. Biankin A.V., Biankin S.A., Kench J.G., et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut 50 (2002) 861-868
32. Hahn S.A., Bartsch D., Schroers A., et al. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res 58 (1998) 1124-1126
33. Argani P., Shaukat A., Kaushal M., et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer 91 (2001) 1332-1341
34. Abraham S.C., Lee J.H., Hruban R.H., Argani P., Furth E.E., and Wu T.T. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol 34 (2003) 902-910